Tocqueville Asset Management’s Zymeworks ZYME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-10,679
Closed -$134K 561
2024
Q3
$134K Buy
10,679
+377
+4% +$4.11K ﹤0.01% 517
2024
Q2
$87.7K Sell
10,302
-838
-8% -$7.46K ﹤0.01% 516
2024
Q1
$117K Buy
+11,140
New +$124K ﹤0.01% 522

Other funds holding ZYME

Tocqueville Asset Management's ZYME Position: Q4 2024 in Review

Tocqueville Asset Management sold out of Zymeworks (ZYME) in Q4 2024, closing a stake of 10,679 shares — an estimated $134K sold.

Tocqueville Asset Management first reported a position in ZYME in Q1 2024 and held it in 3 quarters. The position peaked at $134K in Q3 2024. 172 funds tracked by Wall St. Rank hold ZYME as of Q4 2024.

  • Tocqueville Asset Management reported no remaining Zymeworks position as of Q4 2024 after selling out during the quarter.
  • Tocqueville Asset Management sold 10,679 Zymeworks shares in Q4 2024, an estimated $134K.
  • Tocqueville Asset Management first reported a position in Zymeworks in Q1 2024 and held it in 3 quarters.
  • Tocqueville Asset Management's Zymeworks position peaked at $134K in Q3 2024.
  • 172 funds tracked by Wall St. Rank held Zymeworks as of Q4 2024.

Based on Tocqueville Asset Management's 13F filing for Q4 2024, filed 10 Feb 2025.